KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Non-Current Liabilities (2016 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $7.6 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 98.2% year-over-year to $7.6 million; the TTM value through Mar 2026 reached $7.6 million, down 98.2%, while the annual FY2025 figure was $7.6 million, 98.07% down from the prior year.
  • Other Non-Current Liabilities hit $7.6 million in Q1 2026 for Alnylam Pharmaceuticals, roughly flat from $7.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $439.7 million in Q3 2025 and bottomed at $7.6 million in Q4 2025.
  • Average Other Non-Current Liabilities over 5 years is $261.8 million, with a median of $280.7 million recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities soared 139.37% in 2022 and then crashed 98.2% in 2026.
  • Alnylam Pharmaceuticals' Other Non-Current Liabilities stood at $212.6 million in 2022, then surged by 45.09% to $308.4 million in 2023, then grew by 27.46% to $393.1 million in 2024, then crashed by 98.07% to $7.6 million in 2025, then increased by 0.22% to $7.6 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $7.6 million, $7.6 million, and $439.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.